Gylden’s 2025 Strategic Priorities for Advancing Innovative and Transformative Solutions for Infectious Diseases
Clinical trials planned to begin patient enrollment during 2025 to evaluate Gylden’s T cell Priming (TcP) candidates against Dengue (Phase II) ...
Japan Today2d
CDC layoffs strike deeply at its ability to respond to flu, norovirus, measles outbreaks and other public health emergencies
In just a few short weeks, the Trump administration has brought drastic changes to the Centers for Disease Control and ...
tagtik5d
Global alert with outbreak of deadly Ebola virus (WHO)
WHO, the World Health Organization, has confirmed the existence of a new outbreak of the Marburg virus, a disease that has ...
Raleigh News & Observer6d
NanoViricides, Inc. Has Filed its Quarterly Report
West Nile Virus, Ebola/Marburg viruses, and certain Coronaviruses. The Company intends to obtain a license for RSV, Poxviruses, and/or Enteroviruses if the initial research is successful. As is ...